HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ikko Kajihara Selected Research

Collagen Diseases (Collagen Disease)

5/2020Increased CD27 expression in the skins and sera of patients with systemic sclerosis.
1/2019A case of overlap syndrome (scleroderma and polymyositis) associated with the development of sudden chest pain due to myocardial damage.
9/2013Serum levels of tenascin-C in collagen diseases.
5/2013Scleroderma dermal fibroblasts overexpress vascular endothelial growth factor due to autocrine transforming growth factor β signaling.
9/2011Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ikko Kajihara Research Topics

Disease

21Neoplasms (Cancer)
01/2022 - 05/2014
19Systemic Scleroderma (Systemic Sclerosis)
06/2022 - 02/2012
15Fibrosis (Cirrhosis)
06/2022 - 02/2012
12Melanoma (Melanoma, Malignant)
01/2022 - 01/2016
10Psoriasis (Pustulosis Palmaris et Plantaris)
03/2022 - 04/2013
10Hemangiosarcoma (Angiosarcoma)
10/2021 - 02/2015
9Extramammary Paget Disease (Paget Disease, Extramammary)
01/2022 - 02/2015
8Dermatomyositis (Dermatopolymyositis)
01/2019 - 09/2011
6Autoimmune Diseases (Autoimmune Disease)
05/2020 - 04/2012
5Collagen Diseases (Collagen Disease)
05/2020 - 09/2011
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2017 - 10/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2022 - 11/2020
3Ulcer
08/2017 - 09/2013
3Cicatrix (Scar)
08/2017 - 09/2013
3Rheumatic Diseases (Rheumatism)
10/2015 - 07/2012
3Localized Scleroderma (Morphea)
09/2013 - 01/2013
2Microsatellite Instability
05/2022 - 02/2022
2Dermatofibrosarcoma
05/2022 - 04/2018
2Circulating Neoplastic Cells
01/2022 - 02/2019
2Neoplasm Metastasis (Metastasis)
07/2021 - 02/2019
2Pemphigus (Pemphigus Vulgaris)
01/2021 - 08/2017
2Psoriatic Arthritis
09/2020 - 04/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2020 - 04/2015
2Sclerosis
01/2020 - 04/2013
2Erythema
01/2020 - 08/2017
2Carcinogenesis
05/2019 - 10/2017
2Hypoxia (Hypoxemia)
02/2019 - 06/2014
2Cutaneous Fistula
03/2014 - 04/2013
1Inflammation (Inflammations)
09/2021
1Lymphatic Metastasis
07/2021
1Merkel Cell Carcinoma
11/2020
1Behcet Syndrome (Behcet's Syndrome)
11/2020
1Myelitis
09/2020
1Disease Progression
08/2020

Drug/Important Bio-Agent (IBA)

13CollagenIBA
06/2022 - 02/2012
11Proteins (Proteins, Gene)FDA Link
10/2021 - 11/2015
11MicroRNAs (MicroRNA)IBA
01/2020 - 04/2012
10DNA (Deoxyribonucleic Acid)IBA
03/2022 - 07/2012
10Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2013
7Bleomycin (Blenoxane)FDA LinkGeneric
06/2022 - 04/2013
7CytokinesIBA
02/2021 - 02/2012
6Cell-Free Nucleic AcidsIBA
03/2022 - 09/2020
4Immune Checkpoint InhibitorsIBA
09/2021 - 12/2016
4Infliximab (Remicade)FDA Link
01/2019 - 04/2016
4EnzymesIBA
07/2017 - 09/2011
3Pharmaceutical PreparationsIBA
01/2022 - 07/2017
3AntigensIBA
02/2021 - 12/2016
3Collagen Type I (Type I Collagen)IBA
12/2020 - 04/2012
3Docetaxel (Taxotere)FDA Link
01/2020 - 02/2015
3Messenger RNA (mRNA)IBA
07/2017 - 05/2013
3Silver Sulfadiazine (SSD)FDA LinkGeneric
10/2015 - 09/2013
3ImmunosorbentsIBA
09/2013 - 09/2011
2alpha2 Subunit Collagen Type IIBA
06/2022 - 09/2015
2Small Interfering RNA (siRNA)IBA
06/2022 - 11/2020
2PromegaIBA
05/2022 - 02/2022
2Interleukin-23 (Interleukin 23)IBA
01/2022 - 01/2017
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2021 - 04/2020
2Peptides (Polypeptides)IBA
02/2021 - 01/2020
2Interleukin-17 (Interleukin 17)IBA
02/2021 - 04/2012
2AntibodiesIBA
10/2020 - 07/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 01/2014
2AutoantibodiesIBA
08/2020 - 05/2020
2LigandsIBA
05/2020 - 05/2020
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 02/2015
2Interleukin-8 (Interleukin 8)IBA
09/2018 - 07/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2017 - 01/2013
2IntegrinsIBA
09/2015 - 01/2013
1Janus KinasesIBA
03/2022
1Circulating MicroRNAIBA
01/2022
1Circulating Tumor DNAIBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
09/2021
1Early Growth Response Protein 1IBA
09/2021
1Janus Kinase 2IBA
07/2021
1Nucleosomes (Nucleosome)IBA
04/2021
1EpitopesIBA
02/2021
1ParaffinIBA
02/2021
1avelumabIBA
11/2020
1Tumor Viral Antigens (Large T Antigen)IBA
11/2020
1Transcription Factors (Transcription Factor)IBA
11/2020
1Prednisolone (Predate)FDA LinkGeneric
11/2020
1HLA-A*26 antigenIBA
11/2020
1PaxillinIBA
10/2020
1SurvivinIBA
10/2020
1cadherin 5IBA
10/2020
1taxaneIBA
10/2020
1EndoglinIBA
10/2020
1Caspase 3 (Caspase-3)IBA
10/2020
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2020
1MethylprednisoloneFDA LinkGeneric
09/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2020

Therapy/Procedure

17Therapeutics
07/2021 - 02/2015
3Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 02/2015
2Immunotherapy
02/2021 - 01/2020
2Radiotherapy
05/2020 - 01/2019
2Negative-Pressure Wound Therapy
03/2014 - 04/2013
2Skin Transplantation (Skin Grafting)
03/2014 - 04/2013
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2021
1Aftercare (After-Treatment)
02/2021
1Injections
02/2021